|
Name |
penicipurate A
|
Molecular Formula | C19H28O6 | |
IUPAC Name* |
(5-formyl-3,4-dihydroxy-2,6-dimethylphenyl)3-hydroxydecanoate
|
|
SMILES |
CCCCCCCC(O)CC(=O)Oc1c(C)c(O)c(O)c(C=O)c1C
|
|
InChI |
InChI=1S/C19H28O6/c1-4-5-6-7-8-9-14(21)10-16(22)25-19-12(2)15(11-20)18(24)17(23)13(19)3/h11,14,21,23-24H,4-10H2,1-3H3/t14-/m1/s1
|
|
InChIKey |
SJFKFQGSOSQWAP-CQSZACIVSA-N
|
|
Synonyms |
NA
|
|
CAS | NA | |
PubChem CID | NA | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 352.43 | ALogp: | 3.5 |
HBD: | 3 | HBA: | 6 |
Rotatable Bonds: | 10 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 104.1 | Aromatic Rings: | 1 |
Heavy Atoms: | 25 | QED Weighted: | 0.191 |
Caco-2 Permeability: | -4.78 | MDCK Permeability: | 0.00002640 |
Pgp-inhibitor: | 0.002 | Pgp-substrate: | 0.446 |
Human Intestinal Absorption (HIA): | 0.023 | 20% Bioavailability (F20%): | 0.181 |
30% Bioavailability (F30%): | 0.003 |
Blood-Brain-Barrier Penetration (BBB): | 0.281 | Plasma Protein Binding (PPB): | 98.85% |
Volume Distribution (VD): | 0.35 | Fu: | 1.57% |
CYP1A2-inhibitor: | 0.787 | CYP1A2-substrate: | 0.38 |
CYP2C19-inhibitor: | 0.23 | CYP2C19-substrate: | 0.496 |
CYP2C9-inhibitor: | 0.51 | CYP2C9-substrate: | 0.763 |
CYP2D6-inhibitor: | 0.008 | CYP2D6-substrate: | 0.192 |
CYP3A4-inhibitor: | 0.211 | CYP3A4-substrate: | 0.109 |
Clearance (CL): | 11.973 | Half-life (T1/2): | 0.835 |
hERG Blockers: | 0 | Human Hepatotoxicity (H-HT): | 0.008 |
Drug-inuced Liver Injury (DILI): | 0.027 | AMES Toxicity: | 0.051 |
Rat Oral Acute Toxicity: | 0.032 | Maximum Recommended Daily Dose: | 0.455 |
Skin Sensitization: | 0.915 | Carcinogencity: | 0.203 |
Eye Corrosion: | 0.963 | Eye Irritation: | 0.936 |
Respiratory Toxicity: | 0.746 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC000863 | 0.411 | D0I4DQ | 0.295 | ||||
ENC001313 | 0.410 | D0D9NY | 0.287 | ||||
ENC000972 | 0.410 | D0WY9N | 0.270 | ||||
ENC001612 | 0.388 | D06FEA | 0.259 | ||||
ENC004248 | 0.375 | D09ANG | 0.259 | ||||
ENC002841 | 0.372 | D01WUA | 0.259 | ||||
ENC003533 | 0.358 | D0MM8N | 0.255 | ||||
ENC001217 | 0.358 | D0AY9Q | 0.253 | ||||
ENC004428 | 0.356 | D0G2KD | 0.252 | ||||
ENC004427 | 0.353 | D02MLW | 0.252 |